- Home
- / PanCryos
PanCryos
Total Funding
$83.6 K
PanCryos Summary
Company Summary
- Overview
- PanCryos is a company that aims to develop a stem cell-derived allogeneic cell therapy (PanINSULA) for type 1 diabetes. Based on novel IP, it provides safety and large scale manufacturing of insulin cells for therapeutic use.
- Type
- Private
- Status
- Active
- Founded
- 2015
- HQ
- København, DK | view all locations
- Website
- http://pancryos.com/
- Cybersecurity rating
- Sectors
Table of Contents
LocationsView all
2 locations detected
København HQ
Denmark
Ole Maaløes Vej 3, 3b building
København
Denmark
Blegdamsvej 3B, Building 6, 5th floor
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026